We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
From 1 April, we're introducing the new role of Director of the Parkinson's Virtual Biotech alongside the existing role of Director of Research.
Date
An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson's with levodopa-induced dyskinesias.
Date
Researchers compared results from over 150 studies to understand how different types of physical activity can be used to manage Parkinson's symptoms.
Date
Research into how the brain works, and what happens when things go wrong, is vital to help us find better treatments for Parkinson's.
Date
NICE has conditionally recommended 5 remote monitoring devices for Parkinson's for use in the NHS in England.
Date
This International Day of Women and Girls in Science we're celebrating some of the pioneering women who are driving Parkinson's research forward.
Date
A Lord's inquiry supported by Parkinson's UK has recommended the UK government urgently prioritises funding and support for clinical research.
Date
Results from a large study show how changes in certain bacteria may play a part in the development and progression of Parkinson's.
Date
Through the Parkinson's Virtual Biotech, we're investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson's.
Date
From exciting research breakthroughs, to running marathons. We're celebrating all of our community's fantastic achievements this year.